Latest Circulating Tumor Cell Stories
-Enhanced Offering to Enable 'Dynamic Monitoring' in Cancer Research- RARITAN, N.J., Aug.
Investment will support scale of global services, development of independent diagnostic tests, and deployment of future companion diagnostic products SAN DIEGO, July 30, 2014 /PRNewswire/
SAN DIEGO, July 30, 2014 /PRNewswire/ -- Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops
Discovery Accepted into NCI Drug Development Program for Clinical Trials Philadelphia, PA (PRWEB) July 28, 2014 An estimated 68,000 women and men in
The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at
Transparency Market Research published a new report "Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014
HER3-positive circulating tumor cells home in on omentum; new target to thwart metastasis
Circulating tumor cells captured with a microchip-based device developed at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine and the MGH Cancer Center can be cultured to establish cell lines for genetic analysis and drug testing.
Strategic dealmaker to advance Epic's leading circulating tumor cell (CTC) technology as a rapid and non-invasive platform for on-label, marketed companion diagnostics SAN DIEGO, May
Fully automated system effectively isolates and retrieves circulating tumour cells for timely, tailored treatment of cancer CHICAGO, May 27, 2014 /PRNewswire/ -- Clearbridge BioMedics
- A poem in which the author retracts something said in an earlier poem.